Terumo (OTCMKTS:TRUMY) Stock Passes Below 50 Day Moving Average – Should You Sell?

Shares of Terumo Corp. (OTCMKTS:TRUMY) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $13.13 and traded as low as $13.00. Terumo shares last traded at $13.14, with a volume of 262,052 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Nomura upgraded Terumo to a “hold” rating in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold”.

Terumo Stock Performance

The company has a quick ratio of 0.89, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The business has a 50 day moving average price of $13.13 and a two-hundred day moving average price of $14.78. The stock has a market cap of $19.38 billion, a P/E ratio of 22.66 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). Terumo had a net margin of 11.74% and a return on equity of 9.01%. The business had revenue of $1.94 billion for the quarter, compared to the consensus estimate of $1.82 billion.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.